A T-ALL order: a new risk classifier for T-ALL
Deepa Bhojwani, MD, Jun J. Yang, PhD, Ching-Hon Pui, MD, Pediatric clinics of North America, Vol: 62, Issue: 1,
מאמרים נבחרים
Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma (J Cline Oncol)
10:08
סגור לתגובות על Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma (J Cline Oncol)
Abstract Purpose: Current clinical challenges in Hodgkin lymphoma (HL) include difficult-to-treat relapsed/refractory disease and considerable long-term toxicities of treatment. Since clinical
Utilization of Palliative Radiation in Pediatric Oncology Patients During the End-of-life (EOL)
11:42
סגור לתגובות על Utilization of Palliative Radiation in Pediatric Oncology Patients During the End-of-life (EOL)
Abstract Background Suffering at the end-of-life (EOL) can impact the perception of a “good death” and ultimately affect bereavement for
Integrative medicine in oncology: redefining the standard of care
11:34
סגור לתגובות על Integrative medicine in oncology: redefining the standard of care
Integrative medicine incorporated alongside cancer care, referred to as integrative oncology, is an evidence-informed field with established clinical guidelines. Although
Precision oncology across the ages: Impact on children, adolescents, and young adults
11:31
סגור לתגובות על Precision oncology across the ages: Impact on children, adolescents, and young adults
Abstract: Precision oncology endeavors to tailor therapies based on individual patient and tumor characteristics. This rapidly evolving field has transformed
Immunotherapies for Childhood Cancer
11:24
סגור לתגובות על Immunotherapies for Childhood Cancer
Abstract Children are surviving cancer in greater numbers than ever. Over the last 50 years, substantial advancements in pediatric cancer
IKZF1 in acute lymphoblastic leukemia: the rise before the fall?
14:06
סגור לתגובות על IKZF1 in acute lymphoblastic leukemia: the rise before the fall?
Abstract Acute lymphoblastic leukemia (ALL) is the most common malignancy in children and adolescents and in recent decades, the survival
High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular Immunotherapy
13:59
סגור לתגובות על High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular Immunotherapy
Abstract Immunotherapy has emerged as an attractive option for patients with relapsed or refractory high-risk neuroblastoma (HRNB). Neuroblastoma (NB), a
Pediatric cancer-pathology and microenvironment influence: a perspective into osteosarcoma and non-osteogenic mesenchymal malignant neoplasms
13:35
סגור לתגובות על Pediatric cancer-pathology and microenvironment influence: a perspective into osteosarcoma and non-osteogenic mesenchymal malignant neoplasms
The Lancet Oncology , Volume 17 , Issue 10 , 1396 - 1408
International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents
13:25
סגור לתגובות על International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents
Abstract Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumours that arise not only in adulthood but also in childhood and
